Induction of apoptosis in HL-60 cells by eicosapentaenoic acid (EPA) is associated with downregulation of bcl-2 expression

Cancer Lett. 1999 Oct 18;145(1-2):17-27. doi: 10.1016/s0304-3835(99)00224-4.

Abstract

Dietary polyunsaturated fatty acids (PUFAs) have been reported as a potential group of natural products which modulate tumor cell growth. In present study, eicosapentaenoic acid (EPA) was found to inhibit proliferation of human leukemic HL-60 and K-562 cells in vitro. EPA arrested cell cycle progression at G0/G1 phase, and induced necrosis in both HL-60 and K-562 cells. However, EPA induced apoptosis only in HL-60 but not K-562 cells. Also, bcl-2 protein expression was downregulated in much greater extent than that of bax showing that depression of bcl-2 might be an important step during the EPA-induced apoptosis in HL-60 cells.

MeSH terms

  • Apoptosis / drug effects*
  • Down-Regulation
  • Drug Screening Assays, Antitumor
  • Eicosapentaenoic Acid / pharmacology*
  • Flow Cytometry
  • G1 Phase / drug effects
  • HL-60 Cells
  • Humans
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / drug therapy*
  • Leukemia, Myelogenous, Chronic, BCR-ABL Positive / pathology
  • Leukemia, Promyelocytic, Acute / drug therapy*
  • Leukemia, Promyelocytic, Acute / pathology
  • Proto-Oncogene Proteins c-bcl-2 / biosynthesis*
  • Resting Phase, Cell Cycle / drug effects
  • Tumor Cells, Cultured

Substances

  • Proto-Oncogene Proteins c-bcl-2
  • Eicosapentaenoic Acid